澳门老奇人论坛

Meeting Coverage >

AAO

Long-Term LASIK Outcomes in Myopia Beat Out Rival SMILE Procedure

Results point to effectiveness of LASIK in more challenging cases, researcher says

Patients on New Thyroid Eye Disease Drug Are OK With Ear Problems

Few discontinued teprotumumab due to hearing loss, tinnitus

Eye Surgeons Divided Over Same-Day Bilateral Cataract Surgeries

New AAO guidelines urge caution, say patients should make final decision

Seeing Intraocular Inflammation? Consider Syphilitic Uveitis

Study finds significant increase in U.S. incidence from 2011 to 2016

Anti-Sweat Wipes Tied to Kids' Temporary Eye Troubles

Using hyperhydrosis-reducing wipes -- and then touching eyes -- may led to pupil changes

Conjugate Active in Exudative Retinal Diseases

Improved vision, decreased retinal thickening with antibody-biopolymer agent

Eye Imaging May Give Early Clues to Alzheimer's

Abnormal retinal vasculature in two separate studies

Metformin May Cut AMD Risk in Diabetes

Almost a 50% risk reduction versus nonusers

Diabetes No Barrier to Cataract Surgery

Procedure shouldn't be delayed solely on basis of HbA1c levels, researcher says

No Vision Benefit with Anti-VEGF Plus Steroid

Combo did reduce retinal thickening in diabetic macular edema

AAO: Intravitreal Chemo Effective But Toxic

Optimal interval between injections remains unclear

AAO: Antibiotic Resistance Common in Ocular Infections

Continued methicillin resistance and S. pneumonias resistance to azithromycin doubles

AAO: High Myopia Corrected with Collamer Lens

Endothelial cell loss is minimal

AAO: Topical NSAID Prevents PCME in Cataract Patients With Risk Factors

Study supports off-label use

AAO: Portable Low Vision Device Makes Life Easier

Low vision patients gain independence

AAO: Presbyopia Under Attack by Novel Therapies

Each approach has advantages over traditional procedures

AAO: IRIS Registry Is Data Goldmine

With 100 million patient visits logged, benchmark data emerges

Compounder Tied to Tainted Eye Meds, Lost Sight

CHICAGO -- All but one of 12 patients given injections of contaminated bevacizumab (Avastin) prepared by a compounding pharmacy permanently lost vision in the affected eye, researchers reported here.